Logo image of IFOS.CA

ITAFOS INC (IFOS.CA) Stock Fundamental Analysis

TSX-V:IFOS - TSX Venture Exchange - KYG497151087 - Common Stock - Currency: CAD

2.23  -0.06 (-2.62%)

Fundamental Rating

6

Taking everything into account, IFOS scores 6 out of 10 in our fundamental rating. IFOS was compared to 32 industry peers in the Chemicals industry. While IFOS has a great profitability rating, there are some minor concerns on its financial health. IFOS has a bad growth rate and is valued cheaply. These ratings could make IFOS a good candidate for value investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

IFOS had positive earnings in the past year.
In the past year IFOS had a positive cash flow from operations.
In multiple years IFOS reported negative net income over the last 5 years.
Of the past 5 years IFOS 4 years had a positive operating cash flow.
IFOS.CA Yearly Net Income VS EBIT VS OCF VS FCFIFOS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

1.2 Ratios

The Return On Assets of IFOS (1.55%) is better than 79.31% of its industry peers.
IFOS has a better Return On Equity (3.25%) than 79.31% of its industry peers.
IFOS's Return On Invested Capital of 13.98% is amongst the best of the industry. IFOS outperforms 100.00% of its industry peers.
IFOS had an Average Return On Invested Capital over the past 3 years of 19.24%. This is significantly above the industry average of 8.82%.
The last Return On Invested Capital (13.98%) for IFOS is well below the 3 year average (19.24%), which needs to be investigated, but indicates that IFOS had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.55%
ROE 3.25%
ROIC 13.98%
ROA(3y)9.15%
ROA(5y)-2.8%
ROE(3y)28.45%
ROE(5y)-20.02%
ROIC(3y)19.24%
ROIC(5y)N/A
IFOS.CA Yearly ROA, ROE, ROICIFOS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300

1.3 Margins

With a decent Profit Margin value of 2.19%, IFOS is doing good in the industry, outperforming 75.86% of the companies in the same industry.
The Operating Margin of IFOS (22.46%) is better than 96.55% of its industry peers.
In the last couple of years the Operating Margin of IFOS has grown nicely.
IFOS has a better Gross Margin (28.32%) than 86.21% of its industry peers.
IFOS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 22.46%
PM (TTM) 2.19%
GM 28.32%
OM growth 3YN/A
OM growth 5Y72.57%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y24.6%
IFOS.CA Yearly Profit, Operating, Gross MarginsIFOS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

6

2. Health

2.1 Basic Checks

IFOS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for IFOS has been increased compared to 1 year ago.
IFOS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, IFOS has an improved debt to assets ratio.
IFOS.CA Yearly Shares OutstandingIFOS.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
IFOS.CA Yearly Total Debt VS Total AssetsIFOS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 1.02, we must say that IFOS is in the distress zone and has some risk of bankruptcy.
IFOS has a Altman-Z score of 1.02. This is comparable to the rest of the industry: IFOS outperforms 51.72% of its industry peers.
IFOS has a debt to FCF ratio of 2.57. This is a good value and a sign of high solvency as IFOS would need 2.57 years to pay back of all of its debts.
The Debt to FCF ratio of IFOS (2.57) is better than 100.00% of its industry peers.
A Debt/Equity ratio of 0.28 indicates that IFOS is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.28, IFOS is doing good in the industry, outperforming 65.52% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 2.57
Altman-Z 1.02
ROIC/WACC1.49
WACC9.38%
IFOS.CA Yearly LT Debt VS Equity VS FCFIFOS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.66 indicates that IFOS has no problem at all paying its short term obligations.
IFOS has a Current ratio of 2.66. This is in the better half of the industry: IFOS outperforms 72.41% of its industry peers.
A Quick Ratio of 1.21 indicates that IFOS should not have too much problems paying its short term obligations.
IFOS has a Quick ratio (1.21) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.66
Quick Ratio 1.21
IFOS.CA Yearly Current Assets VS Current LiabilitesIFOS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.93% over the past year.
The Revenue for IFOS has decreased by -21.53% in the past year. This is quite bad
Measured over the past years, IFOS shows a quite strong growth in Revenue. The Revenue has been growing by 9.03% on average per year.
EPS 1Y (TTM)3.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%350%
Revenue 1Y (TTM)-21.53%
Revenue growth 3Y21.4%
Revenue growth 5Y9.03%
Sales Q2Q%80.52%

3.2 Future

The Earnings Per Share is expected to decrease by -9.07% on average over the next years.
IFOS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.49% yearly.
EPS Next Y5.26%
EPS Next 2Y-11.86%
EPS Next 3Y-9.07%
EPS Next 5YN/A
Revenue Next Year7.17%
Revenue Next 2Y4.21%
Revenue Next 3Y1.49%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IFOS.CA Yearly Revenue VS EstimatesIFOS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
IFOS.CA Yearly EPS VS EstimatesIFOS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -2 -4 -6 -8 -10

9

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 3.14 indicates a rather cheap valuation of IFOS.
Based on the Price/Earnings ratio, IFOS is valued cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.63, IFOS is valued rather cheaply.
With a Price/Forward Earnings ratio of 5.02, the valuation of IFOS can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IFOS indicates a rather cheap valuation: IFOS is cheaper than 100.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.68. IFOS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 3.14
Fwd PE 5.02
IFOS.CA Price Earnings VS Forward Price EarningsIFOS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IFOS is valued cheaper than 100.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IFOS indicates a rather cheap valuation: IFOS is cheaper than 96.55% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.47
EV/EBITDA 2.37
IFOS.CA Per share dataIFOS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IFOS has an outstanding profitability rating, which may justify a higher PE ratio.
IFOS's earnings are expected to decrease with -9.07% in the coming years. This may justify a cheaper valuation.
PEG (NY)0.6
PEG (5Y)N/A
EPS Next 2Y-11.86%
EPS Next 3Y-9.07%

0

5. Dividend

5.1 Amount

IFOS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ITAFOS INC

TSX-V:IFOS (2/21/2025, 7:00:00 PM)

2.23

-0.06 (-2.62%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)03-21 2025-03-21
Inst Owners0.55%
Inst Owner ChangeN/A
Ins Owners1.21%
Ins Owner ChangeN/A
Market Cap416.59M
Analysts84
Price Target4.34 (94.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.27%
Min EPS beat(2)48.51%
Max EPS beat(2)98.02%
EPS beat(4)4
Avg EPS beat(4)115.35%
Min EPS beat(4)48.51%
Max EPS beat(4)204.46%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)36.9%
Min Revenue beat(2)5.26%
Max Revenue beat(2)68.54%
Revenue beat(4)4
Avg Revenue beat(4)32.01%
Min Revenue beat(4)5.26%
Max Revenue beat(4)68.54%
Revenue beat(8)7
Avg Revenue beat(8)17.54%
Revenue beat(12)10
Avg Revenue beat(12)13.13%
Revenue beat(16)12
Avg Revenue beat(16)10.82%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)44.83%
EPS NY rev (3m)44.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)2.92%
Revenue NY rev (3m)5.02%
Valuation
Industry RankSector Rank
PE 3.14
Fwd PE 5.02
P/S 0.62
P/FCF 7.47
P/OCF 2.58
P/B 0.92
P/tB 0.92
EV/EBITDA 2.37
EPS(TTM)0.71
EY31.84%
EPS(NY)0.44
Fwd EY19.93%
FCF(TTM)0.3
FCFY13.39%
OCF(TTM)0.86
OCFY38.76%
SpS3.59
BVpS2.42
TBVpS2.42
PEG (NY)0.6
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.55%
ROE 3.25%
ROCE 18.51%
ROIC 13.98%
ROICexc 15.78%
ROICexgc 15.78%
OM 22.46%
PM (TTM) 2.19%
GM 28.32%
FCFM 8.33%
ROA(3y)9.15%
ROA(5y)-2.8%
ROE(3y)28.45%
ROE(5y)-20.02%
ROIC(3y)19.24%
ROIC(5y)N/A
ROICexc(3y)20.74%
ROICexc(5y)N/A
ROICexgc(3y)20.74%
ROICexgc(5y)N/A
ROCE(3y)25.46%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y91%
ROICexc growth 3YN/A
ROICexc growth 5Y91%
OM growth 3YN/A
OM growth 5Y72.57%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y24.6%
F-Score4
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 2.57
Debt/EBITDA 0.64
Cap/Depr 225.96%
Cap/Sales 15.77%
Interest Coverage 12.79
Cash Conversion 81.85%
Profit Quality 379.59%
Current Ratio 2.66
Quick Ratio 1.21
Altman-Z 1.02
F-Score4
WACC9.38%
ROIC/WACC1.49
Cap/Depr(3y)133.15%
Cap/Depr(5y)105.67%
Cap/Sales(3y)8.86%
Cap/Sales(5y)9.13%
Profit Quality(3y)433.5%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%350%
EPS Next Y5.26%
EPS Next 2Y-11.86%
EPS Next 3Y-9.07%
EPS Next 5YN/A
Revenue 1Y (TTM)-21.53%
Revenue growth 3Y21.4%
Revenue growth 5Y9.03%
Sales Q2Q%80.52%
Revenue Next Year7.17%
Revenue Next 2Y4.21%
Revenue Next 3Y1.49%
Revenue Next 5YN/A
EBIT growth 1Y-51.15%
EBIT growth 3YN/A
EBIT growth 5Y88.15%
EBIT Next Year13.91%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-75.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-42.69%
OCF growth 3YN/A
OCF growth 5YN/A